More than 45 million Americans have nasal allergies, more than 22 million have asthma and over 10 million have both. Respiratory diseases take a devastating toll on public health, costing billions of dollars in direct medical expenses, reducing quality of life, lowering workplace and school performance, and can be life-threatening to high-risk populations, such as asthma patients.
5 State Survey Shows Patients Want Access
Following AAFA's first national PSE poll in 2010 and follow-up national poll again in 2013 showing that the majority of asthma, allergy, cold and flu patients opposed changing popular OTC medications to Rx status, the nonprofit patient organization worked with Harris Interactive to conduct a 2015 follow-up study to look more into the access issues that patients face in five key states. The results show that a clear majority of patients continue to prefer access. See the links below for more information about the 2015 5-state update.
About the 2015 Survey Update
AAFA conducted a special updated survey in 5 key states – IL, IN, OK, TN, MO – January 14 to 26, 2015, among 2,027 U.S. adults age 18+ who personally experienced cold, cough, flu, asthma and/or nasal allergies in the preceding 12 months and purchased non-prescription medications for at least one condition during that time. The survey was conducted for AAFA by Harris Poll. Results were weighted to Census targets for education, age/gender, race/ethnicity, region and household income. Propensity score weighting was also used to adjust for respondents’ propensity to be online.
For more information on AAFA's 2015 report and for previous survey findings, see the links below.